Cetera Investment Advisers Cuts Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
3 Articles
3 Articles
Cetera Investment Advisers Cuts Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Cetera Investment Advisers lowered its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 1.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 53,105 shares of the company’s stock after selling 899 shares during the period. Cetera Investment Advisers’ holdings in Teva Pharmaceutical Industries were worth $1,170,000 …
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by Cetera Investment Advisers
Cetera Investment Advisers reduced its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 1.7% during the 4th quarter, HoldingsChannel.com reports. The fund owned 53,105 shares of the company’s stock after selling 899 shares during the quarter. Cetera Investment Advisers’ holdings in Teva Pharmaceutical Industries were worth $1,170,000 at the end of the […]
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Consensus Recommendation of “Buy” from Analysts
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has earned a consensus rating of “Buy” from the eight analysts that are presently covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage